MHP
ETON icon

Manatuck Hill Partners’s Eton Pharmaceutcials ETON Stock Holding History

Manatuck Hill Partners’s Portfolio ETON Stock Details ETON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-40,000
Closed -$987K – 139
2026
Q1 		$987K Buy
+40,000
New +$699K 0.27% 81

Other funds holding ETON

OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
OAM
Oberweis Asset Management Lisle, Illinois $4.84B AUM 160.95% 1-Year Est. Return
NPT
National Philanthropic Trust Jenkintown, Pennsylvania $6.92B AUM 24.7% 1-Year Est. Return

Manatuck Hill Partners's ETON Position: Q2 2026 in Review

Manatuck Hill Partners sold out of Eton Pharmaceutcials (ETON) in Q2 2026, closing a stake of 40,000 shares — an estimated $987K sold.

Manatuck Hill Partners first reported a position in ETON in Q1 2026 and held it in 1 quarter. The position peaked at $987K in Q1 2026. 165 funds tracked by Wall St. Rank hold ETON as of Q2 2026.

  • Manatuck Hill Partners reported no remaining Eton Pharmaceutcials position as of Q2 2026 after selling out during the quarter.
  • Manatuck Hill Partners sold 40,000 Eton Pharmaceutcials shares in Q2 2026, an estimated $987K.
  • Manatuck Hill Partners first reported a position in Eton Pharmaceutcials in Q1 2026 and held it in 1 quarter.
  • Manatuck Hill Partners's Eton Pharmaceutcials position peaked at $987K in Q1 2026.
  • 165 funds tracked by Wall St. Rank held Eton Pharmaceutcials as of Q2 2026.

Based on Manatuck Hill Partners's 13F filing for Q2 2026, filed 14 Aug 2026.